HUMAN BETA DEFENSINS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES Application EP-2320929-B1 European Patent Office 29 May 2019
Oral treatment of inflammatory bowel disease Grant US-9833495-B2 United States of America 05 Dec 2017
Treatment of inflammatory bowel diseases with mammal beta defensins Grant US-9279010-B2 United States of America 08 Mar 2016
Oral treatment of inflammatory bowel disease Grant US-9217021-B2 United States of America 22 Dec 2015